Biology of Blood and Marrow Transplantation

1

Allogeneic Hematopoietic Cell Transplantation for Chronic Myelofibrosis in Australia and New Zealand: Older Recipients Receiving Myeloablative Conditioning at Increased Mortality Risk

Ian Nivison-Smith, Anthony J. Dodds, Jason Butler, Kenneth F. Bradstock, David D.F. Ma, Judy M. Simpson, Jeff Szer

Journal:

Year:

2012

Language:

english

File:

PDF, 176 KB

english, 2012

2

Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment

Nandita Khera, Jack Jinneman, Barry E. Storer, Shelly Heimfeld, Megan M. O’Meara, Thomas R. Chauncey, Stephanie J. Lee, Michael Linenberger

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 217 KB

english, 2012

3

Effect of Early Posttransplantation Tacrolimus Concentration on the Development of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors

Takehiko Mori, Jun Kato, Takayuki Shimizu, Yoshinobu Aisa, Tomonori Nakazato, Akiko Yamane, Yukako Ono, Hiroyoshi Kunimoto, Shinichiro Okamoto

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 127 KB

english, 2012

4

EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure

Katayoun Rezvani, Edward J. Kanfer, David Marin, Ian Gabriel, Amin Rahemtulla, Alexandra Taylor, Donald MacDonald, Francesco Dazzi, Dragana Milojkovic, Letizia Foroni, Jiri Pavlu, Jeremy Sargent, Rifc

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 230 KB

english, 2012

5

Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

Peter R. Holman, Caitlin Costello, Margarida deMagalhaes-Silverman, Sue Corringham, Januario Castro, Edward D. Ball

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 195 KB

english, 2012

6

Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients

Rosa F. Yeh, Matthew A. Pawlikowski, David K. Blough, George B. McDonald, Paul V. O’Donnell, Andrew Rezvani, H. Joachim Deeg, Jeannine S. McCune

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 340 KB

english, 2012

7

Genetic Variations in the Mycophenolate Mofetil Target Enzyme Are Associated with Acute GVHD Risk after Related and Unrelated Hematopoietic Cell Transplantation

Weijie Cao, Haowen Xiao, Xiaoyu Lai, Yi Luo, Jimin Shi, Yamin Tan, Weiyan Zheng, Jingsong He, Wanzhuo Xie, Li Li, Xiujin Ye, Xiaohong Yu, Maofang Lin, Zhen Cai, He Huang

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 138 KB

english, 2012

8

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from the SFGM-TC

J.O. Bay, A. Cabrespine, C. Faucher, R. Tabrizi, P. Bordigoni, A. Berceanu, V. Coiteux, M. Renaud, V. Mialou, M. Robin, M. Kuentz, P. Chevallier, N. Dhédin, A. Huynh, F. Garban, F. Witz, A. Buzyn, T.

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 217 KB

english, 2012

9

Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: A Report from the SFGM-TC

Patrice Chevallier, Richard M. Szydlo, Didier Blaise, Reza Tabrizi, Mauricette Michallet, Madalina Uzunov, Nathalie Fegueux, François Guilhot, Simona Lapusan, Nicole Gratecos, Jean-Yves Cahn, Gerard S

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 195 KB

english, 2012

10

Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma

Immacolata Attolico, Vincenzo Pavone, Angelo Ostuni, Bernardo Rossini, Maurizio Musso, Alessandra Crescimanno, Massimo Martino, Pasquale Iacopino, Giuseppe Milone, Patrizia Tedeschi, Sabrina Coluzzi,

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 156 KB

english, 2012

11

Development and Validation of a Test Dose Strategy for Once-Daily i.v. Busulfan: Importance of Fixed Infusion Rate Dosing

S. Bill Kangarloo, Farrukh Naveed, Ella S.M. Ng, M. Ahsan Chaudhry, Judy Wu, Nizar J. Bahlis, Christopher B. Brown, Andrew Daly, Peter Duggan, Michelle Geddes, Diana Quinlan, Mary Lynn Savoie, Mona Sh

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 268 KB

english, 2012

12

Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplantation Clinical Trials

Ellen M. Denzen, Martha E. Burton Santibáñez, Heather Moore, Amy Foley, Iris D. Gersten, Cathy Gurgol, Navneet S. Majhail, Ryan Spellecy, Mary M. Horowitz, Elizabeth A. Murphy

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 501 KB

english, 2012

13

Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study

Philippe Armand, Haesook T. Kim, Mei-Jie Zhang, Waleska S. Perez, Paola S. Dal Cin, Thomas R. Klumpp, Edmund K. Waller, Mark R. Litzow, Jane L. Liesveld, Hillard M. Lazarus, Andrew S. Artz, Vikas Gupt

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 500 KB

english, 2012

14

Stable Long-Term Pulmonary Function after Myeloablative Double Cord Blood Transplant

Filippo Milano, Jason W. Chien, Ivy Riffkin, Jonathan A. Gutman, Laura Newell, Steven A. Pergam, Colleen Delaney

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 178 KB

english, 2012

15

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Florent Malard, Nicolaus Kröger, Ian H. Gabriel, Kai Hübel, Jane F. Apperley, Grzegorz W. Basak, Kenneth W. Douglas, Catarina Geraldes, Ozren Jaksic, Zdenek Koristek, Francesco Lanza, Roberto Lemoli,

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 88 KB

english, 2012

16

The National Marrow Donor Program’s Symposium on Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment

Navneet S. Majhail, Elizabeth A. Murphy, Ellen M. Denzen, Stacy S. Ferguson, Claudio Anasetti, Arthur Bracey, Linda Burns, Richard Champlin, Norman Hubbard, Miriam Markowitz, Richard T. Maziarz, Erin

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 176 KB

english, 2012

17

The Pretransplantation Serum Cytokine Profile in Allogeneic Stem Cell Recipients Differs from Healthy Individuals, and Various Profiles are Associated with Different Risks of Posttransplantation Complications

Håkon Reikvam, Knut Anders Mosevoll, Guro Kristin Melve, Clara-Cecilie Günther, Malvin Sjo, Pål-Tore Bentsen, Øystein Bruserud

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 560 KB

english, 2012

18

T Cell and B Cell Immunity can be Reconstituted with Mismatched Hematopoietic Stem Cell Transplantation Without Alkylator Therapy in Artemis-Deficient Mice Using Anti-Natural Killer Cell Antibody and Photochemically Treated Sensitized Donor T Cells

Tony Z. Xiao, Kanal Singh, Elizabeth Dunn, Rageshree Ramachandran, Morton J. Cowan

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 676 KB

english, 2012

19

Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease

Avital L. Amir, Renate S. Hagedoorn, Simone A.P. van Luxemburg-Heijs, Erik W.A. Marijt, Alwine B. Kruisselbrink, J.H. Frederik Falkenburg, Mirjam H.M. Heemskerk

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 606 KB

english, 2012

20

Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-versus-Host Disease

Isabel Sánchez-Ortega, Octavio Servitje, Montserrat Arnan, Guillermo Ortí, Teresa Peralta, Federico Manresa, Rafael F. Duarte

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 360 KB

english, 2012

21

A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen

Prakash Satwani, Monica Bhatia, James H. Garvin Jr., Diane George, Filemon Dela Cruz, John Le Gall, Zhezhen Jin, Joseph Schwartz, Deirdre Duffy, Carmella van de Ven, Sandra Foley, Ria Hawks, Erin Morr

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 146 KB

english, 2012

22

My AML Cytogenetics Classification Scheme Is Better Than Yours

Mikkael A. Sekeres

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 54 KB

english, 2012

23

NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive Outcomes

Susan K. Parsons, Sean Phipps, Lillian Sung, K. Scott Baker, Michael A. Pulsipher, Kirsten K. Ness

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 243 KB

english, 2012

24

2012 BMT Tandem Meetings

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 45 KB

english, 2012

25

New Hope for Mobilization Failures . . . Again

John F. DiPersio

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 82 KB

english, 2012

26

Purpose and Scope

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

27

Editorial Board

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 62 KB

english, 2012

28

Officers and Directors of ASBMT

Journal:

Biology of Blood and Marrow Transplantation

Year:

2012

Language:

english

File:

PDF, 74 KB

english, 2012

29

Volume 18; Issue 2

Biology of Blood and Marrow Transplantation

Allogeneic Hematopoietic Cell Transplantation for Chronic Myelofibrosis in Australia and New Zealand: Older Recipients Receiving Myeloablative Conditioning at Increased Mortality Risk

Limiting the Daily Total Nucleated Cell Dose of Cryopreserved Peripheral Blood Stem Cell Products for Autologous Transplantation Improves Infusion-Related Safety with No Adverse Impact on Hematopoietic Engraftment

Effect of Early Posttransplantation Tacrolimus Concentration on the Development of Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation from Unrelated Donors

EBMT Risk Score Predicts Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Who Have Failed a Previous Transplantation Procedure

Idiotype Immunization Following High-Dose Therapy and Autologous Stem Cell Transplantation for Non-Hodgkin Lymphoma

Accurate Targeting of Daily Intravenous Busulfan with 8-Hour Blood Sampling in Hospitalized Adult Hematopoietic Cell Transplant Recipients

Genetic Variations in the Mycophenolate Mofetil Target Enzyme Are Associated with Acute GVHD Risk after Related and Unrelated Hematopoietic Cell Transplantation

Double Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study from the SFGM-TC

Reduced-Intensity Conditioning before Allogeneic Hematopoietic Stem Cell Transplantation in Patients Over 60 Years: A Report from the SFGM-TC

Plerixafor Added to Chemotherapy Plus G-CSF Is Safe and Allows Adequate PBSC Collection in Predicted Poor Mobilizer Patients with Multiple Myeloma or Lymphoma

Development and Validation of a Test Dose Strategy for Once-Daily i.v. Busulfan: Importance of Fixed Infusion Rate Dosing

Easy-to-Read Informed Consent Forms for Hematopoietic Cell Transplantation Clinical Trials

Classifying Cytogenetics in Patients with Acute Myelogenous Leukemia in Complete Remission Undergoing Allogeneic Transplantation: A Center for International Blood and Marrow Transplant Research Study

Stable Long-Term Pulmonary Function after Myeloablative Double Cord Blood Transplant

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

The National Marrow Donor Program’s Symposium on Hematopoietic Cell Transplantation in 2020: A Health Care Resource and Infrastructure Assessment

The Pretransplantation Serum Cytokine Profile in Allogeneic Stem Cell Recipients Differs from Healthy Individuals, and Various Profiles are Associated with Different Risks of Posttransplantation Complications

T Cell and B Cell Immunity can be Reconstituted with Mismatched Hematopoietic Stem Cell Transplantation Without Alkylator Therapy in Artemis-Deficient Mice Using Anti-Natural Killer Cell Antibody and Photochemically Treated Sensitized Donor T Cells

Identification of a Coordinated CD8 and CD4 T Cell Response Directed Against Mismatched HLA Class I Causing Severe Acute Graft-versus-Host Disease

Dasatinib as Salvage Therapy for Steroid Refractory and Imatinib Resistant or Intolerant Sclerotic Chronic Graft-versus-Host Disease

A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen

My AML Cytogenetics Classification Scheme Is Better Than Yours

NCI, NHLBI/PBMTC First International Conference on Late Effects after Pediatric Hematopoietic Cell Transplantation: Health-Related Quality of Life, Functional, and Neurocognitive Outcomes

2012 BMT Tandem Meetings

New Hope for Mobilization Failures . . . Again

Purpose and Scope

Editorial Board

Officers and Directors of ASBMT

Contents